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ABSTRACT Enveloped viruses enter host cells either through endocytosis, or by direct fusion of the viral envelope and the
membrane of the host cell. However, some viruses, such as HIV-1, HSV-1, and Epstein-Barr can enter a cell through either
mechanism, with the choice of pathway often a function of the ambient physical chemical conditions, such as temperature
and pH. We develop a stochastic model that describes the entry process at the level of binding of viral glycoprotein spikes to
cell membrane receptors and coreceptors. In our model, receptors attach the cell membrane to the viral membrane, while subse-
quent binding of coreceptors enables fusion. The model quantiﬁes the competition between fusion and endocytotic entry path-
ways. Relative probabilities for each pathway are computed numerically, as well as analytically in the high viral spike density limit.
We delineate parameter regimes in which fusion or endocytosis is dominant. These parameters are related to measurable and
potentially controllable quantities such as membrane bending rigidity and receptor, coreceptor, and viral spike densities. Exper-
imental implications of our mechanistic hypotheses are proposed and discussed.INTRODUCTION
Entry mechanisms of enveloped viruses (viruses with
a surrounding outer lipid bilayer membrane) are usually clas-
sified as being either endocytotic or fusogenic (1,2). In fusion,
the virus membrane and the host cell membrane become
joined by a pore. Once the two membranes are contiguous,
the virus can directly enter the host cell. This process is typi-
cally mediated by binding of cell surface receptors to glyco-
protein spikes on the viral membrane surface, which trigger
embedded fusion peptides. In endocytosis, the host cell first
internalizes the virus particle, wrapping it in a vesicle before
either fusion with the endosomal membrane, or degradation
of the virus as the endosome is acidified. Fusion of the endo-
somal membrane with the viral envelope is often triggered by
the acidic environment of the endosome.
While viruses are typically thought to enter host cells via
either endocytosis or fusion, there is a growing list of viruses
known to enter cells though both pathways. For example,
influenza, the avian leukosis virus, and Semliki Forest virus
primarily enter cells via endocytosis followed by endosomal
fusion triggered by low pH. However, they have also been
observed to directly fuse with host cells if the pH of the
extracellular environment is lowered (3–5). For some viruses
(e.g., Influenza), the glycoprotein-receptor complexes that
bind the virus to the cell membrane initiate fusion under
acidic conditions encountered later in the process. Many
other viruses require the binding of multiple cell surface
receptors by multiple viral glycoproteins for entry, and
several such viruses have also been observed to enter cells
through their nondominant pathway.
At least three of the 12 types of glycoproteins in the enve-
lope of the Herpes Simplex Virus-1 (HSV-1) bind cell
surface receptors as integral steps in viral entry. As an initial
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proteoglycans on the cell surface, attaching the virus to the
host cell. Once the viral and host cell membranes are brought
close to each other, glycoprotein gD can associate with any
of a number of cell receptors, including Herpesvirus entry
mediator (a tumor necrosis factor receptor), nectin-1 (a
member of the immunoglobulin superfamily), and 3-O-
sulfated heparan sulfate (HS), to trigger fusion. HSV-1 is
known to exploit at least three entry pathways: direct fusion
with the host cell membrane, endocytosis followed by fusion
with an acidic endosome, and endocytosis followed by
fusion with a neutral endosome (6).
Epstein-Barr virus, another member of the Herpes virus
family, requires the binding of multiple glycoproteins to
cell surface receptors during entry. When Epstein-Barr
virions enter B-cells, the glycoprotein complex gp350/220
binds to complement receptor type II (CR2) to attach the
virus to the host B-cell. Fusion of the virus with the cell
membrane or endosome requires that glycoprotein gp42
associate with a HLA class II protein on the cell surface
(7). It is thought that the virus and cell membranes must
be brought close by gp350/220-CR2 binding before gp42
can bind a HLA class II protein. While the Epstein-Barr
virus typically enters B cells by endocytosis, eventually
fusing with the endosome, it enters epithelial cells by direct
fusion with the plasma membrane. There are at least three
models for the entry of Epstein-Barr virus into epithelial
cells;
1. An interaction between gp350/220 on the virus and CR2
on the cell brings the membranes close. Viral glycopro-
tein complex gHgL can then interact with gHgL receptor
on the cell, triggering fusion.
2. The viral glycoprotein complex may directly interact with
its receptor on the cell membrane, triggering fusion.
doi: 10.1016/j.bpj.2009.01.018
Mechanisms of Viral Entry 26253. The viral protein encoded by BMRF2 may interact with
integrins on the cell surface followed by gHgL-gHgLr
binding which triggers fusion (8).
Human immunodeficiency virus (HIV) has also been
shown to exploit both entry mechanisms. HIV requires
a receptor, CD4, for endocytosis, and both CD4 and a core-
ceptor, usually CXCR4 or CCR5, to fuse with the host cell
membrane (9,10). The HIV coreceptor binds to the viral
glycoprotein gp120 with a much higher affinity if the glyco-
protein spike is already bound to a CD4 receptor (11–13).
HIV infects cells with which it fuses, and is typically inacti-
vated upon endocytosis (10).
A previous study (14) has examined the dynamics of viral
entry when a single type of cell receptor attaches the virus to
the cell membrane and induces fusion. In this article, we
develop a stochastic model that describes viral entry path-
ways in which binding of a receptor to viral glycoprotein
spikes is followed by binding of a coreceptor to viral spikes.
In this model, the receptors are only attachment factors and
the coreceptors induce fusion. The coreceptors and receptors
may both bind to the same viral glycoprotein, as is the case
for HIV, or they may bind to different glycoproteins or sets
of glycoproteins, as is the case for HSV-1 and the Epstein-
Barr virus. The selection of entry pathway is computed as
a function of the kinetic rates in the model. We will discuss
the sensitivity of pathway selection to the local coreceptor-
mediated fusion rate and the rate of coreceptor binding. In
Discussion and Conclusions, we will also estimate the role
of active cellular processes in viral uptake by introducing
separate rates for such active processes.
Table 1 lists relevant physical parameters for HIV-1 and
HSV that guide assumptions of our model. Parameter values
relevant to our model, but not readily available, are left blank
and await future experimental investigation.
TABLE 1 Known representative parameter values for virus
spikes, receptors, and coreceptors, and their article references
Quantity HIV-1 HSV-1
Radius R 0.05 mm (52) 0.1 mm (53)
Spikes/virus 8–14 (55,56) 235–480 gD (54)
~700 total (44)
Receptor KD z 5 nM (57)
Binding DHz 100 kBT (57)
Coreceptor KD z 4 nM (58)
Binding DHz 300 kBT (59)
Receptor diff. 0.044 mm2/s (60)
Const. Dr
Coreceptor diff. 0.05 mm2/s (60)
Const. Dc
Host cell radius T-cell Epithelial cell
4 mm (61) 5 mm (62)
Cell receptor 300–3000 6–9  106
Density CD4/mm2 (63) HS/mm2 (64)
Cell coreceptor 60 CCR5/mm2 (63)
DensityKINETIC MODEL FOR RECEPTOR-CORECEPTOR
ENGAGEMENT
Here, we derive a stochastic model describing the competition
between the endocytic and fusion viral entry pathways. We
assume that receptors on a host cell membrane can bind to
any one of M spikes uniformly distributed on the surface of
a single virus, and that coreceptors can bind to any one of
N spikes, which may be different from the spikes to which
receptors bind (see Fig. 1). Receptor binding locally attaches
the virus envelope to the cell membrane, while coreceptor
binding leads to the formation of fusion-enabling complexes.
For simplicity, we consider the binding of both receptors and
coreceptors to be irreversible. Since binding interactions
between receptors and spikes can be very strong and/or have
low dissociation constants (see Table 1), this approximation
is consistentwith physical parameters relevant tomanyviruses.
However, there is also evidence that theCD4-gp120 interaction
is weak and can dissociate during coreceptor recruitment (15).
We assume that only those coreceptor-binding spikes in
a region where spikes are bound to receptors can bind core-
ceptors. This assumption is appropriate if the receptors act
as the attachment factor that brings the viral and cell
membranes close enough for the coreceptor to bind. For
example, the binding of CR2 receptors to the large gp350/
220 glycoprotein complex on the Epstein-Barr virus typi-
cally precedes attachment of fusion-inducing HLA class II
proteins to the smaller gp42 glycoprotein. This assumption
also applies to HIV, since the affinity of coreceptors for viral
spikes increases significantly if the spike has already bound
a receptor (11–13).
The ratio of coreceptor-binding spikes to receptor-binding
spikes is defined by r ¼ N/M. For viruses where attachment
receptors and fusion initiating coreceptors attach to the same
glycoprotein spike, such as HIV-1, we can simply set r ¼ 1
in our model. Although we assume that each spike can bind
at most only one receptor and/or one coreceptor, experimen-
tally inferred stoichiometries range from one to a handful
(16–18). Our model can be straightforwardly adapted to
describe specific receptor/coreceptor/spike stoichiometries.
For endocytosis to occur, the virus must be fully wrapped
by the cell membrane. We assume that when the virus is fully
wrapped all receptor-binding spikes have a receptor attached.
However, as more of the cell membrane contacts the virus
membrane through receptor binding, the rate of binding of
fusion-inducing coreceptors increases and fusion is increas-
ingly likely.
Although CD4 is known to coordinate accumulation of
leukocyte-specific protein tyrosine kinase enhancing T cell
sensitivity to antigens (19), we are not aware of any evidence
of such cooperativity at the molecular level in the spike-
receptor-coreceptor HIV fusion system. It has been shown
that for HIV, viral spike trimers act independently to induce
fusion (20), so in this case, we will assume that each spike-
receptor-coreceptor complex represents a fusion-enablingBiophysical Journal 96(7) 2624–2636
2626 Nowak and ChouFIGURE 1 A schematic of the kinetic steps involved in receptor and coreceptor engagement, which ultimately lead to membrane fusion or endocytosis.
Receptors and coreceptors in the cell membrane are represented by black line segments and red zigzags, respectively. The projected contact area nucleated
by the number of bound receptors is also shown. Only viral spikes that have a coreceptor bound can induce fusion. Endocytosis can occur only when the contact
region grows to the surface area of the virus particle. (Left) The receptors and coreceptors both bind to the same viral spikes (blue circles). An example of such
a virus is HIV-1, where spikes, likely composed of trimers of gp120/41, bind to both CD4 and CCR5. (Right) An example (such as herpes simplex virus) in
which coreceptors and receptors bind to different spikes, with the ratio of receptor-binding spikes (blue circles) to coreceptor-binding spikes (yellow hexagons)
defined by r.trimer. Since we are only interested in the first instant any
one of the spike-receptor-coreceptor triggers irreversible
fusion, when the fusion entry pathway is chosen, our model
assumes the total rate of fusion will be proportional to the
number of existing spike-receptor-coreceptor complexes.
Within our stochastic model, the likely pathway of virus
entry, endocytosis, or fusion, will also depend on the specific
rates of receptor and coreceptor binding. These rates will be
first motivated by simple physical considerations. A mathe-
matical framework representing our stochastic model is
found by considering, at any given time t, the probability
Pm,n(t) that m spikes are bound to a receptor and n spikes
are bound to a coreceptor. With the definition of the relevant
rates in our problem, as follows,
pm,n, rate of binding an additional receptor;
qm,n, rate of binding an additional coreceptor;
kf, fusion rate for each spike-receptor-coreceptor
complex;
ke, rate of endocytosis (membrane pinch-off) when all
viral spikes are receptor-bound (m ¼ M);
the probability Pm,n(t) evolves according to the Master
equation,
vPm;nðtÞ
vt
¼ pm1;nPm1;n þ qm;n1Pm;n1 1%m%N  1; 1%n%n  1
pm;n þ qm;n þ nkfPm;n; nðmÞhintðrmÞ
vPm;n ðtÞ
vt
¼ qm;n1Pm;n1 

pm;n1 þ nkf

Pm;n ; 1%m%M  1
vPm;0ðtÞ
vt
¼ pm1;0Pm1;0 

pm;0 þ qm;0

Pm;0; 1%m%M  1;
vPM;nðtÞ
vt
¼ pM1;nPM1;n þ qM;n1PM;n1 1%n%N  1;
qM;n þ nkf þ kePM;n:
(1)Biophysical Journal 96(7) 2624–2636
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ke)PM,0, and vtPM,N ¼ pM1,NPM1,N þ qM,N1PM,N1 
(Nkfþ ke)PM,N. The process depicted in Fig. 1 and described
by the above expressions in Eq. 1 can be represented by
transitions within the m, n-state space shown in Fig. 2.
We treat all transitions in ourmodel asMarkovian, implicitly
assuming that they do not depend on past configurations. This
assumption is appropriate if the attachment rates are kinetically
limited by membrane fluctuations or by receptor/coreceptor
binding, rather than by diffusion. Diffusion-limited binding
of receptors and coreceptors gives rise to history-dependent
kinetics andmust be treatedwithin the framework of stochastic
moving boundary problems. (Deterministic moving boundary
problems relevant for virus wrapping are treated in P.-W. Fok
andT.Chou (21) and (22).) For binding kinetics to not be diffu-
sion-limited, receptors and coreceptors must diffuse fast
enough to replenish a receptor-depleted region before the
next binding event occurs. The time required for concentration
variations to diffuse away is ar,c/Dr,c, where ar and ac are the
typical areas per receptor and coreceptor on the cell surface,
and Dr and Dc are their diffusion coefficients in the cell
membrane. Therefore, provided
pm;n  Dr=ar and qm;n  Dc=ac; (2)
diffusion will not contribute to history-dependent binding.
For the HIV infection systems, CD4 receptor and CCR5
coreceptor concentrations are ~103/mm2 and 60/mm2, respec-
tively. Upon using the cell surface receptor and coreceptor
diffusion coefficients in Table 1, we find that pm,n  50/s
and qm,n  3/s, and are required for CD4 and CCR5
engagement to be kinetically limited, and not diffusion-
limited.
Within our coarse-grained Markov chain, the history-
independent binding assumption also requires neglect of
FIGURE 2 Two-dimensional state space for receptor and coreceptor-medi-
ated viral entry. Each state corresponds to a virus particle bound to m% M
receptors and n% N ¼ rM coreceptors. In this example, the fraction of cor-
eceptor-binding spikes to receptor-binding spikes is r¼ 1/2. The probability
fluxes through the fusion and endocytosis pathways are indicated by the red
and green arrows, respectively. A representative trajectory of the stochastic
process that results in endocytosis is indicated by the blue dashed curve.active cell processes, such as those involving a signaling
cascade, or aggregation of signaling proteins on the cell
membrane. However, our coarse stochastic model can still
capture the qualitative effects of these active processes
provided the rates are interpreted as effective parameters and
a new parameter representing the timescale of active processes
is introduced. We defer discussion of active processes to
Discussion and Conclusions.
Although our main qualitative findings are independent of
the precise form for the attachment rates pm,n and qm,n, we
nonetheless examine a specific physical model for these rates.
First, assume that a receptor binds, with rate pm,n, to only
those spikes that are within some small distance ‘ of the
contact line L(m) (see Fig. 3) where the membrane detaches
from the virus. A functional form for this rate can be derived
by considering the number of ways additional receptors can
bind, given that there are alreadym receptor-spike complexes
making up the contact region. Fluctuations of the cell
membrane will be distributed in size with a typical scale ‘
(Fig. 3). The plasma membrane fluctuations, either thermally
excited, or driven by cellular processes such as cytoskeletal
reorganization (23), can be caught by the virus if they bring
a receptor into the proximity of a spike. As shown in Fig. 3,
the membrane-wrapping process is a Brownian ratchet
that uses the spikes within a distance ‘ of the contact line of
length L(m) to catch the cell membrane fluctuations. The
rate of attachment of an additional receptor can be written as
pm,n ~ drdsu‘L(m)as
1ar
1, where u is an intrinsic attempt
rate for binding and fluctuations of typical size ‘, dr,s are
receptor and spike sizes, as
1 is the viral spike concentration,
and ar
1 is the receptor concentration on the cell membrane.
The term ‘L(m)as
1 represents the probability that
amembrane fluctuation of typical size ‘will encounter a spike
on the viral surface whenm receptors have already previously
bound. The approximate spherical geometry of this system
gives LðmÞz2pR½1 ð1 2m=MÞ21=2, and since the area
per spike is as z 4pR
2/M, we find the coreceptor-indepen-
dent, receptor binding rate to be
FIGURE 3 A schematic of a partially wrapped virus particle. The
unbound spikes above the contact region are represented by light-blue
circles, while the receptor-bound spikes in the contact region are represented
by the dark-blue circles. Spikes that are bound to coreceptors are indicated
by the red circles. The unbound receptors and coreceptors on the cell
membrane (green) are not shown.Biophysical Journal 96(7) 2624–2636
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where p1M is the intrinsic rate of binding the second receptor
when initially one is bound. This intrinsic rate depends on
a number of physical parameters such as cell membrane
bending rigidity (through ‘ and u) and cell surface receptor
concentration. For stiff membranes under tension, amembrane
wrapping a spherical particle encounters an energy barrier near
half-wrapping (24).This canbe incorporated into the dynamics
by assuming p1 has an M dependence with a minimum near
m z M/2. Other forms for pm,n can also be motivated (25)
by considering the mechanics of wrapping (26).
The binding rate of coreceptors will be proportional to the
integer number of receptor-spike complexes that have not yet
bound to coreceptors,
qm;nzq1;0intðrm nÞhq1ðnðmÞ  nÞ; (4)
where q1 is the intrinsic rate of a coreceptor binding to
a spike-receptor complex.
Finally, we describe the fusion and endocytosis steps. The
rates of these processes, kf and ke, are the least well measured.
The individual fusion rates kf depend not only on the particular
spike-receptor complex, but also may depend on other molec-
ular factors such as the lipid composition. We assume that
each spike-receptor-coreceptor complex (or complex trimer)
spontaneously and independently triggers fusion with rate
kf, after it has formed. In model systems involving the gp41
fusion peptide of the HIV-1 glycoprotein-receptor complex,
the fusion rate was found to be ~kf ~0.01/s (27). Physical
models for kf can also be motivated from phenomenological
considerations of fusion intermediates (28–31) and/or esti-
mated from computer simulations (31,32).
The pinching-off of membrane vesicles in endocytosis is
potentially a more complex process activated by GTPases
such as dynamin (33). The kinetics of this process may be
akin to the kiss-and-run fast mode of endocytosis at neuronal
synapses. A wide range of rates (0.1/s < ke < 20/s) for
synaptic vesicle kinetics has been reported (34).
NUMERICAL SOLUTION OF MASTER EQUATION
Solutions to Eq. 1 can be found numerically for up to reason-
ably large values of M and N. From the resulting probabili-
ties, we construct time-independent quantities of interest.
The total time integrated probability Qe that the virus
undergoes endocytosis can be constructed from
Qe ¼ ke
XN
n¼ 1
Z N
0
PM;nðtÞdt: (5)
Similarly, the total time-integrated probability Qf that the
virus undergoes fusion isBiophysical Journal 96(7) 2624–2636Qf ¼ kf
X
m;n%n
n
Z N
0
Pm;nðtÞdt ¼ 1 Qe; (6)
where the last equality arises from conservation of proba-
bility and the assumption of nondetaching receptors.
We solve for Qe and Qf by taking the Laplace transform
of Eq. 1 and setting s ¼ 0. If we define ~Pm;n ¼RN
0 e
stPm;nðtÞdt, then the endocytosis and fusion probabili-
ties can be expressed as Qe ¼
P
n ke
~Pm;nðs ¼ 0Þ and Qf ¼P
m;n%n nkf
~Pm;nðs ¼ 0Þ, respectively. We can also find the
mean times hTei to viral entry, conditioned upon endocy-
tosis, or hTfi, conditioned upon fusion,
hTei ¼ keQ1e
XN
n¼ 1
Z N
0
tPM;nðtÞdt
¼ keQ1e
XN
n¼ 1
v~PM;nðs ¼ 0Þ
vs
(7)
and

Tf
 ¼ kfQ1f X
m;n<rm
n
Z N
0
tPm;nðtÞdt
¼ kfQ1f
X
m;n%n
n
v~Pm;nðs ¼ 0Þ
vs
:
(8)
Finally, crucial to experimental considerations of spike-
receptor-coreceptor stoichiometry (35), we also compute
the mean numbers of receptors and coreceptors bound to
the virus at the moment of entry. The mean number of recep-
tors bound at the moment of fusion is found from
mf
 ¼ Q1f X
m;n%n
mnkf ~Pm;nðs ¼ 0Þ: (9)
The mean numbers of coreceptors bound at the moment of
fusion, and the mean number of coreceptors bound at the
moment of endocytosis (when all N receptors are bound)
can be similarly obtained.
RESULTS AND ANALYSIS
In this section, we discuss solutions of the Master equation
(Eq. 1). For simplicity, consider that the ratio of the number
of spikes that can bind coreceptors to the number of spikes
that can bind receptors is r ¼ 1 and thatM ¼ N. This implies
either that the number of receptor-binding spikes equals the
number of coreceptor binding spikes, or that receptors and cor-
eceptors both bind the same spikes, as is the case for HIV. The
results for rs 1 are qualitatively similar to the results of r¼ 1
when the replacement kf/ rkf is made (see Appendix).
Pathway probabilities
We first explore how the probability that the virus undergoes
endocytosis, Qe, depends on problem parameters. Since
Qe þ Qf ¼ 1, it is sufficient to consider only Qe. In
Fig. 4 a, Qe is plotted as a function of the normalized fusion
Mechanisms of Viral Entry 2629rate, kf/p1, for different values of the normalized intrinsic
coreceptor binding rate, q1/p1. The number of viral spikes,
M ¼ N, was chosen to be 100. The probability that the virus
undergoes endocytosis decreases with increasing fusion rate,
but a small coreceptor binding rate can attenuate fusion even
when kf is large. In Fig. 4 b, we plot the probability that the
virus undergoes endocytosis as a function of normalized
fusion rate, kf/p1, for different values of the normalized endo-
cytosis rate, ke/p1.
The dependence of the endocytosis probability, Qe, on
the number of viral spikes, M, is shown in Fig. 5. Although
the binding rate, pm increases with M (see Eq. 3), so do the
number of spikes that need to be engaged by receptors to
achieve the full wrapping required for endocytosis. The
time required to fully wrap the virus is therefore constant
with respect to M. However, the fusion rate is proportional
to the number of spikes with coreceptors bound and is thus
a
b
FIGURE 4 (a) The probability that the virus undergoes endocytosis is
plotted as a function of the normalized fusion rate, kf/p1, for different values
of the normalized coreceptor binding rate, q1/p1. The probability of endocy-
tosis decreases with increasing fusion rate and, for a given fusion rate, the
probability of endocytosis increases with decreasing q1/p1. In this example,
the normalized endocytosis rate, ke/p1¼ 1. (b) For q1/p1¼ 1, the probability
of endocytosis is plotted as a function of fusion rate for different values of
the normalized endocytosis rate, ke/p1. In both plots, the number of
receptor-binding spikes and the number of coreceptor-binding spikes are
set to M ¼ N ¼ 100.proportional to N. As N increases, the probability that the
particle undergoes fusion before it becomes fully wrapped
increases, as illustrated by Fig. 5. Figs. 4 and 5 clearly
show a marked decrease in the endocytosis probability as
the fusion rate kf is increased.
Since kf may vary greatly depending on physical chemical
conditions, as well as on viral species, it is important to esti-
mate the values of kf for which endocytosis or fusion is the
dominant mode of entry. To better understand how Qe
depends on kf, we consider the continuum limit of Eq. 1,
appropriate for largeM, N. The probabilities of full wrapping
and endocytosis, as well as times to fusion and endocytosis,
can be calculated analytically by themethod of characteristics
(see Appendix). Fig. 6 compares our continuum limit analytic
solution with the exact numeric solution and agreement is
FIGURE 5 Endocytosis rates are plotted as a function of M ¼ N. During
wrapping, the fusion rate is proportional to the number of bound coreceptors,
and increases with increasingN (in this case equal toM). The probability that
the virus enters the cell through endocytosis decreaseswith increasingM¼N.
FIGURE 6 The exact numeric solution of Eqs. 1 and 5 for the probability
Qe that the virus undergoes endocytosis is plotted as a function of kfh rkfM/
(2p1), the dimensionless fusion rate and compared to the M/ N asymp-
totic solution (thin solid curves). Two sets of curves, corresponding to
l h q1/(2p1) ¼ 0.1, 2 are shown for M ¼ N ¼ 10, 100, and 1000 (r ¼ 1).
In these plots, the endocytosis rate was taken to be ke/p1 ¼ 2.Biophysical Journal 96(7) 2624–2636
2630good for M, N T 100. The analytic solution (see Eq. 30 in
Appendix) provides a guide for estimating the parameters
for which endocytosis is likely.
Let us now dissect the entry dynamics and estimate values
of ke and kf for which endocytosis will occur. For certain
parameters, the virus is likely to fuse before it becomes fully
wrapped. In this case, the probability that the virus reaches the
fully wrapped state will be small, and fusion will be the domi-
nant mode of entry. Only if the virus is likely to become fully
wrapped is endocytosis a possible alternative to fusion. Endo-
cytosis will occur only if the probability that M receptors
become bound to the virus, PM, is ~1 and endocytosis occurs
more quickly than fusion once the virus is fully wrapped. For
single receptor-spike complexes that attach membranes and
induce fusion (14), previous asymptotic analysis showed that
kfM
2
pm

 1 (10)
must be satisfied for the virus to become fully wrapped. In
that analysis, pm was a typical receptor binding rate.
Analogous conditions for endocytosis can be found when
both receptor and coreceptor binding are required for fusion.
These conditions can be found numerically by computing
Qe from Eqs. 1 and 5. However, upon using the specific
forms for the receptor and coreceptor binding rates given
by Eqs. 3 and 4, the conditions can also be deduced from
the wrapping probability PM in the large M limit. From Eq.
25 in the Appendix,
ln PMz rkfM
2p1
	
p
2
 1
2l
þ e
lp  l2
2l

l2 þ 1


; (11)
where l ¼ q1/(2p1). This asymptotic expression allows us to
determinewhen thewrappingprobability is appreciable. If cor-
eceptors are required for fusion, as considered in this study, the
expected behavior will be similar to the single receptor model
only if coreceptor binding is faster than receptor binding.
Indeed, when q1T p1 (lT 1), we find that the condition
rkfM
p1
 1 (12)
is required for full wrapping. Since pm ~ p1M, we recover the
condition (Eq. 10 here) given in Chou (14) when r¼ 1. Fig. 7
a shows the numerically computed probability of full wrap-
ping, PM, as a function of rkfM/p1 (with r¼ 1). The condition
for full wrapping given byEq. 12 holds evenwhen parameters
are individually varied over a wide range of values.
Now consider the condition for full wrapping when core-
ceptor binding is slow compared to receptor binding. For
extremely small q1/p1¼ 2l 1/N, theM,N/N continuum
limit for PM (Eq. 11) is not appropriate. When coreceptor
binding is extremely small, no coreceptors bind, and the virus
always becomes fully wrapped independent of kf. However,
for 1/N  q1/p1  1 (or 1/N  l 1). The condition for
PM ~1 derived from Eq. 11 isBiophysical Journal 96(7) 2624–2636
rkfM
p1

q1
p1

 1: (13)
If the condition in Eq. 12 is satisfied, the condition in Eq. 13
will be satisfied provided that q1 % p1. Thus, the condition
in Eq. 12 is sufficient for the virus to become fully wrapped;
however, because slow coreceptor binding can limit the
effects of a fast fusion rate, the condition in Eq. 12 is not
necessary, particularly when coreceptor binding is slow. In
other words, even if rkfM/p1 is large, as long as q1/p1 is small
enough, the condition in Eq. 13 can still be satisfied and full
wrapping can still occur. In Fig. 7 b,PM is plotted as a function
of (rkfM/p1)(q1/p1) with various parameters independently
varied. When coreceptor binding is slow, the condition given
a
b
FIGURE 7 Wrapping probabilities forM¼ N (r¼ 1). (a) For q1T p1, the
probabilityPM that thevirus reaches the fullywrapped state is plotted as a func-
tion of the dimensionless fusion-rate parameter rkfM/p1.When this parameter
is small, PM approaches unity, but when rkfM/p1[ 1, PM is small. (b) When
1/N q1/p1 1, the wrapping probability PM is plotted as a function of the
dimensionless expression (rkf M/p1)(q1/p1). In this case, the transition of PM
from large to small values occurs at (rkf M/p1)(q1/p1) ~ O(1). In both plots,
only one parameter was varied within a group of symbols of the same color
and shape. In a, the number of spikes M was varied within the groups of
circles, and the fusion rate, kf was varied within the groups of triangles. In
b, the number of spikes M was varied within the groups of solid circles, the
fusion rate kf was varied within the groups of open circles, and the coreceptor
binding rate q1 was varied within the groups of triangles.
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reach the fully wrapped state. Although we have used the
particular binding rates pm and qm,n from Eqs. 3 and 4, analo-
gous conditions for PM ~1 can be motivated for general
binding rates (see Appendix).
We can now derive sufficient conditions for endocytosis
after the virus becomes fully wrapped. In the case where
the coreceptor binding rate is large compared to the receptor
binding rate, we expect that when the virus reaches the fully
wrapped state, nearly all N spikes will be coreceptor-bound.
Once the virus is fully wrapped, it fuses with the cell
membrane with total (and maximal) rate Nkf, while it is
endocytosed by the cell with rate ke. Thus, endocytosis
will be the dominant mode of viral entry if
ke[kfN ¼ rkfM: (14)
Provided the virus has a high probability of reaching the fully
wrapped state, ke [ Nkf is always a sufficient, but not
always a necessary condition for endocytosis. When core-
ceptor binding is not fast, we will typically need to consider
the full solution given by Eq. 30 to determine when endocy-
tosis is likely. However, we can consider the limiting case
where the coreceptor binding rate is small compared to
both the receptor binding rate (q1  p1), and the fusion
rate (q1N  kf). In this case, we can assume that fusion is
limited by the coreceptor binding rate, and the condition
required for efficient endocytosis is
ke[q1N ¼ rq1M: (15)
The conditions described above for efficient endocytosis
are summarized in Discussion and Conclusions and delin-
eated in a parameter-space phase diagram.
Mean entry times
We now investigate hTei, the mean viral entry time via the
endocytosis pathway, and hTfi, the mean entry time via the
fusion pathway. The normalized mean times are computed
from Eqs. 7 and 8 and are plotted in Fig. 8 as a function of the
fusion rate per bound coreceptor, kf. Endocytosis is governed
by two potentially rate-limiting steps: viral wrapping, and the
final endocytosis step (pinching-off of the cell membrane). For
small ke, the endocytosis step is rate-limiting, and hTei scales as
1/ke when Qe z 1. For the parameters used in Fig. 8 a, the
receptor binding rates are much faster than the endocytosis
rate; thus, ke is the limiting rate constant. As the fusion rate kf
increases, both the probability of endocytosis,Qe, and themean
endocytosis times, hTei, decrease. One might initially expect
hTfi, but not hTei, to decrease with increasing kf. However,
we expect there to be some distribution of times at which the
virus becomes fullywrapped.A larger fusion ratewill preferen-
tially annihilate trajectories that take longer to reach the fully
wrapped state. Therefore, only trajectories that quickly reach
the fully wrapped state survive to m ¼ M and participate in
endocytosis, resulting in a decreased hTeiwhen kf is increased.In Fig. 8 b, we plot the normalized mean entry times as
a function of ke/p1, the normalized endocytosis rate. We
find that as we increase ke, the mean time hTei decreases
and then plateaus. The plateau occurs when ke is sufficiently
fast that endocytosis is no longer rate-limiting. Rather,
membrane wrapping is the rate-limiting step, and hTei
becomes independent of ke.
Mean receptor/coreceptors bound at entry
Finally, consider the mean numbers of receptors and corecep-
tors bound to the virus at the time of entry. In Fig. 9 a, we plot
hmfi, the mean number of receptors bound when fusion
occurs, and hmi, the mean number of receptors bound when
the virus enters the cell through either pathway, as functions
of q1, the coreceptor binding rate. As q1 increases, Qe
decreases, and the virus is more likely to fuse with the host
cell. Because the virus fuses more rapidly, there is less time
for receptors to bind and hmi decreases. Fig. 9 b shows the
mean number of coreceptors bound to the virus at the time
of entry. For very small coreceptor binding rates, the virus
typically undergoes endocytosis before a coreceptor can
bind, and hnei  1, where hnei is the mean number of
a
b
FIGURE 8 (a) Normalizedmean times to fusion and endocytosis plotted as
functions of kf/p1, the fusion rate per coreceptor-spike complex. Parameters
used were M ¼ N ¼ 100, q1/p1 ¼ 50, ke/p1 ¼ 0.001. (b) Normalized mean
times to fusion and endocytosis plotted as functions of ke/p1. Here, M ¼
N ¼ 100, q1/p1¼ 5, and kf/p1 ¼ 106, were used. For reference, Qe, the cor-
responding probability that the virus undergoes endocytosis is also plotted.Biophysical Journal 96(7) 2624–2636
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However, at least one coreceptormust bind for fusion to occur;
therefore, when q1 is small, the conditional mean number of
bound coreceptors hnfiz 1. As q1 becomes large, the proba-
bility that the virus undergoes endocytosis becomes small,
but the mean number of coreceptors bound to the viruses
that do undergo endocytosis approaches N ¼ 100. We know
that when q1 is large, nz rm. Since full wrapping (m ¼ M)
is required for endocytosis to occur, we also expect hneiz N.
a
b
FIGURE 9 (a) Themean number of receptors bound at themoment of viral
fusion, and the mean number of receptors bound at the moment of viral entry
(regardless of entry pathway) plotted as functions of the normalized corecep-
tor binding rate, q1/p1. (b) The mean number of coreceptors bound at the
moment of fusion and endocytosis, and the average number of coreceptors
bound are plotted as a function of the normalized coreceptor binding rate
q1/p1. The probability that the virus undergoes endocytosis, Qe is plotted
for reference. For both plotsM ¼ N ¼ 100, kf/p1 ¼ 0.1, ke/p1 ¼ 1.Biophysical Journal 96(7) 2624–2636DISCUSSION AND CONCLUSIONS
We have developed a stochastic model describing the
binding of receptors and coreceptors to viral glycoprotein
spikes, and the subsequent competition between endocytosis
and fusion during entry of enveloped viruses. Receptors
function as simple attachment factors in our model, while
subsequent binding of coreceptors enables fusion. We found
parameter regimes in which endocytosis is favored and
derived analytic expressions for the probability of endocy-
tosis in the large spike number limit (M, N / N). Since
the endocytosis and fusion rates, ke and kf, are difficult to
measure, we summarize our results by a (kf  ke) phase
diagram defined by the conditions in Eqs. 12–15 and shown
schematically in Fig. 10.
Our model provides a mechanistic basis for a number of
experimental measurements and observations. For example,
the dual entry pathways of certain viruses suggest that under
certain conditions (delineated in Fig. 10), inhibition of fusion
does not necessarily preclude viral entry through endocytosis.
HIV fusion inhibitors such asEnfuvirtide (T-20) bind the inter-
mediary spike-CD4 complex of HIV-1 (36,37), and reduce kf
by preventing CCR5 from inducing fusion. Maraviroc binds
CCR5 and prevents it from binding the spike-CD4 complex,
effectively reducing q1 and also preventing fusion (38). Since
the virus may still enter through the endocytosis pathway, our
analysis suggests that the effectiveness of fusion inhibitors
relies on endocytic entry being less infective than fusion.
The sensitivity of entry of HIV strains to cell CD4 and
CCR5 levels have recently been quantitatively studied using
cells lines in which expression levels of receptor and core-
ceptor can be independently varied (S. H. Johnston, M. A.
Lobritz, S. Nyugen, Y. J. Bryson, E. J. Arts, T. Chou, and
B. Lee, unpublished). This system provides a way of inde-
pendently varying p1 and q1, and has revealed qualitatively
different usage patterns by different HIV strains. Our model
provides an additional dimension to the analysis of receptor/
coreceptor tropism. If endocytic entry does not significantly
diminish the probability of nuclear entry and productive
infection, it is possible that strains with similar infectivities
actually prefer different entry pathways.
Infection measurements using, for example, luciferase re-
porting of p24 coat protein levels after productive infection,ba c
FIGURE 10 Qualitative phase diagram showing the
regimes of parameter space in which endocytosis is domi-
nant. Diagrams a–c correspond to fast, intermediate, and
slow coreceptor binding, respectively. In all diagrams,
parameters falling within the blue region left of the vertical
thick dashed line favor full viral wrapping before fusion
occurs (PM z 1). In the yellow sector above the thin-
dashed curves, the rate of endocytosis exceeds the effective
rate of fusion in the fully wrapped state. In the green inter-
section of these regions, the virus is likely to reach the fully
wrapped state and undergo endocytosis. Note that when
coreceptor binding is very slow (c), the virus reaches the
fully wrapped state for all values of kf.
Mechanisms of Viral Entry 2633cannot directly determine entry pathways. However, using
singlemolecule imaging techniques, both the timing and entry
pathways can be directly observed (40–42). Such direct
imaging techniquesmaybe able to distinguish themean condi-
tional times to fusion and endocytosis, particularly in systems
with large fusion and endocytosis rates as shown in Fig. 8.
Additionally, kinetic studies have been performed to
extract the stoichiometry of receptors and coreceptors per
spike, per fusion event (16–18,35,43). Even though our anal-
ysis was based on an intrinsic molecular stoichiometry of one
spike, one receptor, and/or one coreceptor, it implies that the
apparent stoichiometry can vary depending on the degree of
wrapping, and on average, the number of spikes that are
receptor/coreceptor-engaged before fusion or endocytosis.
The apparent stoichiometries are defined by hmfi and hnfi
derived from ourmodel and shown in Fig. 9. Cells with higher
surface densities of coreceptors, and hence larger q1, would
more likely fuse before significant wrapping and formation
of spike-receptor-coreceptor complexes occur. Therefore,
a high coreceptor binding rate can present a lower apparent
coreceptor stoichiometry. It would thus be interesting to
measure kinetics and correlate spike/receptor/coreceptor stoi-
chiometry across viral strains with different apparent usage
stoichiometries, and across cell types with varying concentra-
tions of surface receptors and coreceptors.
The assumption that the viral spikes are evenly distributed
on the surface of the virus is valid only if the spikes are immo-
bile on the virus surface during the entry process. Freely
diffusing glycoprotein spikes will preferentially bind to
membrane receptors or coreceptors when the spikes come
near the cell membrane. Thus, spikes with receptors and cor-
eceptors bound would tend to cluster near the bottom of the
virus, precluding full wrapping. In this case, the probability
that the virus enters the cell via fusion would be increased.
It is also possible that the viral glycoproteins form functional
clusters on the viral envelope (44). It is known that the glyco-
protein spikes of recently budded HIV-1 are associated with
the underlying matrix proteins, but that proteolysis occurs
during the maturation process (45,46). If softening of a
maturing virus particle (46) also increases glycoprotein spike
mobility, one would expect that mature HIV-1 would be
biased toward using the fusion pathway.
The model we have developed considers only the rudimen-
tary receptor engagement processes before fusion or endocy-
tosis. Nonetheless, more-complex mechanisms also can be
described by our model, provided the effective rate parame-
ters are properly interpreted, or the model is augmented to
include other intermediary processes. For example, consider
the possibility that binding of the virus to a cell surface
receptor activates an endocytic pathway that increases the
rate by which the virus is wrapped by the cell membrane.
The increasedwrapping ratemay be the result of, for example,
a decreased effective stiffness of the cytoskeleton that allows
the virus to more easily enter the cell (47). An endocytotic
pathway may also rely on the clustering cell surface receptorsand/or coreceptors, as observed in Qi et al. (48), resulting in
a high local receptor/coreceptor concentration near the virus,
thereby effectively increasing the rate of receptor, and
possibly coreceptor binding.
Activated viral entry processes can be incorporated within
our fusion-or-endocytosis model in a qualitative way by
assuming that before activation, receptors and coreceptors
bind with rates p1
i and q1
i, and that after activation receptors
and coreceptors bind with rates p1
a and q1
a, respectively. We
further assume that activation occurs some time ta after the first
receptor binds. And, for simplicity, we will again consider
that M ¼ N and r ¼ 1. In the absence of an active
endocytosis process, two conditions were required for endocy-
tosis to occur:
Condition 1. The virus had to reach the fully wrapped
state; and
Condition 2. Endocytosis had to be faster than fusion in
the fully wrapped state.
If, however, the cell must initiate an active process for endo-
cytosis, an additional condition arises:
Condition 3. The cell must reach the activated state
without the virus undergoing fusion.
All three conditions must be satisfied if activated endocytosis
is to occur. If activation is important, the inactivated receptor
binding rate p1
i is slow such that on average, few receptors
bind before activation occurs and pi1
ﬃﬃﬃﬃ
M
p
(1=ta. In this
case, the third condition can be described in terms of the
effective binding rates as follows.
If the inactivated coreceptor binding rate is fast compared
with the timescale on which activation occurs (q1
i T1/ta),
the virus will survive to the activated state provided
takf  1. If the inactivated coreceptor binding rate is slow
(q1
i  1/ta), it is unlikely that a coreceptor will bind before
the activated state is reached, and the virus will become acti-
vated for any kf. The delay time ta required to activate the
cell’s endocytosis machinery will be relevant if Condition
3 (that the cell reaches the activated state before viral fusion)
is not met, but Conditions 1 and 2 are. In this case, a model
without the activation step would predict that the virus
should undergo endocytosis when it in fact will undergo
fusion. In Table 2, we summarize the criteria under which
all three activated endocytosis conditions are met.
We can also consider the case in which cells undergo
clathrin- or caveolin-dependent endocytosis that competes
with the fusion process (41,49,50). In these cases, the
membrane adhesion, or wrapping rate pm,n is no longer
a function receptor concentration, but is rather a function
of the rate of assembly of clathrin subunits (51) or calveo-
lin, M of which cover the virus. This rate would be a func-
tion of clathrin or caveolin concentration, or of molecules
that recruit them. If the formation of clathrin pits or caveo-
lin occurs successively in an approximately axisymmetric
manner, we expect the functional form for pm,n would beBiophysical Journal 96(7) 2624–2636
2634 Nowak and ChouTABLE 2 Conditions for 1), survival to fully wrapped state after activation; 2), endocytosis being faster than fusion; and 3), reaching
the activated state before fusion
Condition 1 Condition 2 Condition 3
Fast or slow def.
Survival to fully
wrapped state Fast or slow def.
Endocytosis faster
than fusion Fast or slow def.
Survival to
activated state
Fast coreceptor binding
qa1
pa1
T1
kfM
pa1
 1 q
a
1
pa1
T1 ke[ Nkf q
i
1ta T 1 takf  1
Slow coreceptor binding
1
N
 q
a
1
pa1
 1

kfM
pa1

qa1
pa1

 1 q
a
1
pa1
 1;
q1
aN  kf
ke[ Nq1
a q1
ita  1 ta2kf qi1  1unchanged from Eq. 3. Three variants of our model could
apply to fusion under clathrin or caveolin-mediated endo-
cytosis:
Variant 1. If coreceptors can continue to bind viral spikes
and induce fusion in regions of the membrane coated
with clathrin or caveolin, the model described in
this work is directly applicable. In this case, mono-
meric clathrin/caveolins are receptors and M is the
total number of monomers required to encapsulate
the virus.
Variant 2. If receptor binding, but not fusion, is precluded
in regions of the membrane coated by clathrin/caveo-
lin, the coreceptor binding rate is no longer given by
qm,n ¼ q1(n*(m)  n). In this case, coreceptors, like
monomers of clathrin or caveolin, only bind along
the perimeter of the coated membrane region. The cor-
eceptor binding rate then has a form similar to the
receptor (monomeric clathrin/caveolin) binding rate
and is given by qm;nzq1N
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ð1 2mM Þ2
q
. All other
aspects of the model would remain unchanged.
Variant 3. If coreceptors within a region of the membrane
coated by clathrin/caveolin cannot induce fusion, the
virus can still undergo fusion if coreceptors bind to
spikes along the perimeter of the coated region and
induce fusion before the coated region grows enough
to cover the location of the coreceptor. When corecep-
tor binding is fast compared to the rate at which the
protein scaffold assembles, the instantaneous fusion
rate is proportional to the number of spikes near the
contact region. Instead of nkf, the effective m-depen-
dent fusion rate kfN
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ð1 2mM Þ2
q
arises. The fusion
rate depends only on the number m of bound receptors
and the total number N of coreceptors. It is indepen-
dent of the number n of bound coreceptors, rendering
the state space effectively one-dimensional.
APPENDIX: METHOD OF CHARACTERISTICS
Using specific forms for the receptor and coreceptor attachment rates pm,n
and qm,n, analytic expressions for the wrapping and endocytosis probabilities
can be obtained in the large spike number limit M h 1/3/N. Assuming
binding rates given by Eqs. 3 and 4 and defining x ¼ m3, y ¼ rn3, and time
t ¼ 2p1t, we find the continuum limit of the Master equation:Biophysical Journal 96(7) 2624–2636vPðx; y; tÞ
vt
þ V , ½uðx; yÞPðx; y; tÞ ¼ kfyPðx; y; tÞ:
(16)
In Eq. 16, the convection is defined by
uðx; yÞ ¼
 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
xð1 xÞ
p
; lðx  yÞ

; (17)
where lh q1/(2p1) and kf ¼ rkf/(2p13) are renormalized coreceptor binding
and fusion rates. Assuming that the system starts in the state P(x, y, 0) ¼
d(x  3)d(y) (only one receptor attached), the total derivative of P(x(t),
y(t), t) obeys
dPðrðtÞ; tÞ
dt
¼ kfyðtÞPðrðtÞ; tÞ; (18)
provided
drðtÞ
dt
¼ uðxðtÞ; yðtÞÞ: (19)
First consider times before the virus is fully wrapped by the cell membrane.
The components of Eq. 19 give
dxðtÞ
dt
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
xðtÞð1 xðtÞÞ
p
(20)
and
dyðtÞ
dt
¼ lðxðtÞ  yðtÞÞ: (21)
Upon using the initial conditions x(0) ¼ 3z 0 and y(0) ¼ 0, Eqs. 20 and 21
are solved by
xðtÞ ¼ 1
2
ð1 cos tÞ (22)
and
yðtÞ ¼ 1
2
 l
2cost þ lsint þ elt
2

l2 þ 1 %xðtÞ: (23)
Full wrapping of the virus, if it occurs, is defined by x(t*) ¼ 1, where t* ¼
p. Therefore, at time t ¼ t* ¼ p, we can find the fraction of bound corecep-
tors as
yðtÞhy ¼ 2l
2 þ 1 elp
2

l2 þ 1 < 1: (24)
Using the forms for the trajectory r(t), the probability density for times
t% t* can be found upon solving Eq. 18 to give
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1
2l
 t
2
þ l
2ðlsin t  cos tÞ  elt
2l

l2 þ 1


: (25)
The probability density P* that the virus reaches the fully wrapped state
(the continuum analogue of PM shown in Fig. 7) is found by evaluating
P(x(t*) ¼ 1, y(t*) ¼ y*, t*)h P*. This evaluation gives Eq. 11 in the large
M, N limit.
At times t > t*, additional receptors cannot bind, thus, x(t > t*) ¼ 1, and
y(t) follows
dyðtÞ
dt
¼ lð1 yðtÞÞ: (26)
Upon defining z*h 1  y*, Eq. 26 is solved by
yðt > tÞ ¼ 1 zelðtpÞ: (27)
In terms of the renormalized endocytosis rate ke ¼ ke/(2p1), the probability
that the virus has not entered the cell through either fusion or endocytosis at
time t follows
dPðxðtÞ; yðtÞ; tÞ
dt
¼ kf þ kePðxðtÞ; yðtÞ; tÞ; t > t;
(28)
which is solved by
PðtÞ ¼ Pexp kf þ keðt  tÞ
þ kf
l
z

1 elðttÞ: (29)
The probability Qe that the virus particle undergoes endocytosis is then
given by
Qe ¼ ke
Z N
p
PðtÞdt
¼ ke
l
Pekf z
=l
kf
l
z
ðkf þ keÞ=l
g

kf þ ke
l
;
kfz

l

; (30)
where g is the incomplete lower Gamma function. This expression was used
to generate the analytic results plotted in Fig. 6.
Besides our results obtained using the specific forms of receptor and core-
ceptor binding rates, conditions analogous to those in Eqs. 12 and 13 can
also be obtained for general coreceptor-independent binding rate pm by using
simple scaling arguments. When coreceptor binding is fast, q1 T p1, the
probability of fusion is ~kfhnfit*, where
tz
XM
m¼ 1
1
pm
(31)
is the mean conditional wrapping time, and hnfi is the mean number of bound
coreceptors before fusion. For fast coreceptor binding hnfi ~N, and the neces-
sary (but not sufficient) condition for full virus wrapping (PM ~ 1) is
kfN
XM
m¼ 1
1
pm
¼ rkfM
XM
m¼ 1
1
pm
 1: (32)
When coreceptor binding is slow, hnfiz q1Nt* increases linearly with both
time and the number of available coreceptor-biding spikes. In this case, the
necessary condition for virus wrapping becomes
kfq1NðtÞ2¼ rkfMq1
 XM
m¼ 1
1
pm
!2
 1: (33)Upon inserting the smoothly varying forms for pm from Eq. 3 into the above
relationships, they reduce to the conditions in Eqs. 12 and 13, respectively.
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